论文部分内容阅读
慢性肺源性心脏病(肺心病)是由肺组织、肺动脉血管或胸部的慢性病变引起肺组织结构和功能异常,产生肺血管阻力增加肺动脉压力增高使右心扩张、肥大伴有或不伴右心衰竭的心脏病。死亡率很高,基层医院条件有限,部分患者病因短期难以确定,尤其是合并心衰,治疗有一定的难度,正确合理用药显得非常重要。现将本院从2003年—2007年58例慢性肺源性心脏病合并心衰的患者临床药物治疗心得体会介绍如下。
Chronic cor pulmonale (pulmonary heart disease) is caused by chronic lesions of the lung tissue, pulmonary arteries or thorax that cause structural and functional abnormalities in the lung tissue, resulting in increased pulmonary vascular resistance, increased pulmonary artery pressure, dilated right ventricle, hypertrophy with or without right Heart failure heart disease. The mortality rate is very high. The conditions of grass-roots hospitals are limited. The etiology of some patients is difficult to be determined in the short term. In particular, it is difficult to treat heart failure due to the combination of heart failure. It is very important to use drugs correctly and rationally. The hospital now from 2003-2007 58 cases of chronic heart disease with heart failure in patients with clinical drug treatment experience is described below.